drugset
drugset / Trial / NCT00743873

Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

NCT00743873 ↗

Phase 2/3 Completed 50 enrolled Meir Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.

Timeline

Start
2008-01
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Plasma Rich in Growth Factors (PRGF) Unknown 3 mg Intramuscular
Subject Plasma Rich in Growth Factors (PRGF) Unknown 6 mg Intramuscular

Indications

congenital patella dislocation